Carl A. Kukkonen III

Partner

San Diego + 1.858.314.1178

Carl Kukkonen ist seit fast 20 Jahren vor allem im Bereich der strategischen IP-Beratung tätig, dies schließt die Beratung bei Patentverletzungs- und Nichtigkeitsverfahren ein sowie die Vorbereitung und Durchsetzung von Patentanmeldungen, die Beratung bei U.S. und internationalen Markenanmeldungen, Markenstrategien oder Markenrechts- und Urheberrechtsverletzungen sowie in Domain-Namen-Streitigkeiten. Herr Kukkonen hat bereits zahlreiche IP-Audits und Due-Diligence-Untersuchungen für Unternehmen und Investoren bei M&A-Transaktionen oder Börsengängen durchgeführt.

Darüberhinaus verfügt Herr Kukkonen über umfangreiche Kenntnisse in der Strukturierung und Verhandlung von Unternehmens- und Technologietransaktionen. Dies beinhaltet auch die Erstellung von Lizenz-, Kauf- und Entwicklungsverträgen oder anderen Kooperationsvereinbarungen.

Er führte zahleiche Patentanmeldeverfahren im Auftrag von individuellen Erfindern oder multinationalen Konzernen im Bereich Hochtechnologie/Software, Medizintechnik und Energie durch. Seine Expertise im Bereich Hochtechnologie beinhaltet Datenbanktechnologie, Computer- und Netzsicherheit, Künstliche Intelligenz, Unternehmens-Software, Cloud-Computing, Big Data, Blockchains, Mobilfunk-Soft- und Hardware, In-Orbit-Tests, Halbleiter, Telekommunikation, Nanotechnologie, optische Geräte, Computer- und Mikrochips sowie Signal- und Bildbearbeitung.

Im Bereich Medizintechnik umfassten die von ihm bearbeiteten Mandate Vorrichtungen zur Medikamentenabgabe, die Anwendung des Mobilfunks auf dem Gesundheitsmarkt, das digitale Gesundheitswesen, Patientenmonitore, Inkubatoren, Infusionspumpen, physiologische Sensoren einschließlich Kardiomonitore und Blutdruckmessgeräte, optische Technologien und Geräte zur Knochenfixierung.

Seine Expertise im Bereich Energietechnik umfasst Prozess- und Luftdrucksensoren, Solarmodule und -steuerungssysteme, Verteilernetze in der Energieversorgung, Energieeffizienz, industrielle Fertigungstechnologien, Wasser- und Windturbinen, Brennstoffzellen sowie Wasseraufbereitungsanlagen.

Herr Kukkonen verfügt außerdem über Kenntnisse in der Betriebssicherheit im Bergbau und der Sicherheit von Feuerwehreinsätzen, in der Raumfahrt, im Automobil- und Transportbereich und in der Lebensmittelverarbeitung.

Erfahrung

  • Genspark develops patent portfolio and commercial framework for generative AI workspace technologyJones Day is representing Genspark Inc. in connection with the development and prosecution of a strategic patent portfolio directed to protecting its proprietary generative AI workspace technology.
  • West Pharmaceutical Services sells manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System to AbbVieJones Day is advising West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, in the sale of all manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for $112.5 million at close, subject to working capital and other adjustments.
  • Masal builds patent portfolio involving advanced spinal stability technologiesJones Day is representing Masal, Inc. in the development and prosecution of a portfolio of patents involving advanced spinal stability technologies directed to addressing spinal injuries or deformities through vertebral body reconstruction, augmentation, and/or stabilization.
  • Epic Sciences builds patent portfolio for clinical applications of single cell diagnosticsJones Day assists Epic Sciences, Inc. with counseling and development of global patent portfolios related to clinical applications of methods for analyzing and categorizing rare circulating cells, such as diagnosing cancers, analyzing heterogeneity of disease, and predicting resistance to therapies.
  • Epic Sciences develops global patent portfolio for diagnostics involving rare circulating cellsJones Day is assisting Epic Sciences, Inc. with counseling and development of global patent portfolios related to methods for analyzing and categorizing rare circulating cells, e.g., circulating tumor cells (CTCs), circulating endothelial cells (CECs).
  • Cylance builds leading patent portfolio directed to cybersecurity technologies using AIJones Day is representing Cylance Inc. in the development and prosecution of a portfolio of over 150 issued patents directed to AI-enabled cybersecurity technologies.
  • HiddenLayer develops patent portfolio for protecting machine learning models from malicious activitiesJones Day is representing HiddenLayer, Inc. in the development and prosecution of a portfolio of patents directed to protecting machine learning models from malicious attacks and leakage of sensitive information.
  • Organon makes strategic investment in Claria MedicalJones Day advised Organon in the strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy.
  • Halcyon builds patent portfolio directed to AI-based antiransomware technologiesJones Day is representing Halcyon Tech, Inc. in the development and prosecution of a portfolio of patents directed to AI-based antiransomware technologies.
  • Sempra Energy sells PXiSE Energy SolutionsJones Day advised Sempra Energy in the sale of membership interests in PXiSE Energy Solutions to Yokogawa Electric Corporation.
  • SAP wins summary judgment on Teradata trade secret and antitrust claimsJones Day successfully defended SAP, one of the world's leading producers of software for the management of business processes, against trade secret and antitrust claims in a lawsuit filed in the Northern District of California.
  • Bridge to Life announces first close of $56 million growth financingJones Day advised Bridge to Life, Ltd. in its $56 million capital raise consisting of a secured credit facility and a Series A preferred equity investment.
  • Elementary Robotics builds patent portfolio directed to computer vision and ML techniques for analyzing products on manufacturing lines for quality assurance purposesJones Day represents Elementary Robotics, Inc. in the development and prosecution of a portfolio of patents directed to computer vision and machine-learning techniques for analyzing products on manufacturing lines for quality assurance purposes.
  • SAP establishes diverse patent portfolio directed to software and database innovationsJones Day represented a leading enterprise software and database developer SAP SE in managing patent portfolios directed to diverse innovations including database technologies, mobility, UX, cloud computing, and big data.
  • Huntington Ingalls sells San Diego Shipyard to Titan Acquisition HoldingsJones Day advised Huntington Ingalls Industries in the sale of its San Diego Shipyard to Titan Acquisition Holdings.
  • OrbSurgical builds patent portfolio directed to network-connected surgical instruments that utilize AI and surgical theater federated learning architecturesJones Day represents OrbSurgical Ltd. in the development and prosecution of a portfolio of patents directed to network-connected surgical instruments that utilize AI and surgical theater federated learning architectures.
  • CalypsoAI raises $13 million in Series A roundJones Day represented CalypsoAI, a leader in validation, security, and monitoring for artificial intelligence and machine learning, in connection with the $13 million Series A fundraising led by Paladin Capital Group.
  • EVQLV builds patent portfolio directed to AI-enabled drug discovery technologiesJones Day is representing EVQLV, Inc., a New York based, venture-backed startup, in the development and prosecution of a portfolio of patents directed to AI-enabled drug discovery technologies.
  • CORSAIR® acquires SCUF Gaming®Jones Day advised CORSAIR® in connection with the acquisition and related financing of high-performance controller pioneer SCUF Gaming "SCUF®" and its extensive patent portfolio.
  • Cylance acquired by BlackBerry for $1.4 billionJones Day advised Cylance, an artificial intelligence and cybersecurity leader, in its $1.4 billion acquisition by BlackBerry Limited, plus the assumption of unvested employee incentive awards.
  • Weitere Veröffentlichungen

    • September 21, 2022
      Patent Law Considerations For Drug Discovery Innovations Utilizing Artificial Intelligence
    • June 2021
      Trials and Tribulations - Focus on Digital Therapeutics (Intellectual Property Magazine)
    • January 2019
      Intellectual Property Owners Association (IPO) - 35 USC 101 Subject Matter Eligibility Cases Involving Software-Related Inventions
    • October 11, 2018
      An Introduction to the Risks of AI for General Counsel, Corporate Counsel
    • June 2018
      Protecting Artificial Intelligence Innovations Through Patents, IP Litigator
    • November 21, 2015
      Indefiniteness: Are You Reasonably Certain?
    • 2014
      USPTO Issues Interim Guidance on Patent Eligibility Under §101
    • 2011
      The Law That Protects the Appearance of Your Website
    • 2010
      USPTO Expands Green Technology Pilot Program to Cover More Inventions, Energy & Clean Technology
    • 2008
      A Look at the Changing Landscape of Patent Prosecution, San Diego Business Journal
    • 2007
      More Companies Seek Patents in Unconventional Areas, Boston Business Journal
    • 2007
      Emerging Patent Issues in Cleantech, IP Law 360 / Energy Law 360
    • 2007
      Expanding Preconceptions of Patentable Matter, bizSanDiego
    • 2007
      When in Doubt, Spell It Out: Complying with a Patentee's Duty of Disclosure, San Diego Daily Transcript

    • August 20, 2026
      Buying & Selling the Black Box: Deal Structures and Diligence for AI M&A (WashU Law)
    • September 26, 2026
      Global Enablement & Disclosure Strategies for AI-related Patent Applications (IPO Annual Conference)
    • June 17, 2026
      Building the Shield: IP Strategy for Growth and Innovation
    • June 2026
      Drug-device Combination IP strategy: Maximizing Utility, Design, and Trade Dress Protection
    • January 11, 2026
      AI in Global Drug Development From Target Discovery to Clinical Execution — how AI is Transforming Speed and Precision in Biopharma Global Biopharma Leadership Forum 2026
    • November 17, 2025
      PTAB and Federal Circuit Treatment of AI Subject Matter Eligibility
    • October 21, 2025
      IP Strategy for AI and Fintech
    • March 26, 2025
      Understanding AI-Generated Trade Secrets and Potential Risks
    • March 25, 2025
      PTAB 2025 – Strategic Considerations in a Period of USPTO Change
    • March 6, 2025
      Recent Updates on AI and IP (Patent and Copyright) - Intellectual Property Owners Association (IPO) Spring Summit
    • October 22, 2024
      FinAccelerate: IP Strategies for Fintech
    • September 23, 2024
      IP Protection for Complex AI Innovations in Pharma & MedTech (IPO Annual Meeting)
    • May 9, 2024
      Written Description and Sufficiency for AI Inventions (IPO)
    • May 7, 2024
      Risks, Challenges, and Opportunities Facing Pharma Companies as Drug Development Enters the Age of Artificial Intelligence
    • March 28, 2024
      Generative AI Raising New Copyright Issues
    • March 28, 2024
      BioPharma and AI Patent Strategy Bootcamp
    • March 7, 2024
      Sufficiency of Disclosure for AI Inventions (IPO Spring Summit)
    • January 17, 2024
      Generative AI and the Future of Creativity: A New Copyright Landscape
    • December 7, 2023
      Predictable Arts Patent Drafting Strategies
    • November 28, 2023
      GenAI Year in Review: Intersection of AI and IP
    • October 12, 2023
      Brave New World? Intellectual Property Rights in the Artificial Intelligence Age
    • October 10, 2023
      IP Strategy for Fintech
    • September 27, 2023
      Generative AI: The New Copyright Frontier
    • June 14, 2023
      Generative AI and Emerging IP Issues
    • April 28, 2023
      Software Patents – The Ongoing Saga - PLI Patent Law Institute 2023
    • March 29, 2023
      PTAB Strategy Updates in View of Recent Developments
    • March 17, 2023
      "IP and the Rise of Generative AI" - USD School of Law Patent Law Conference
    • January 27, 2023
      MedFuel Conference
    • September 19, 2022
      Strategic Open Source and IP Considerations for AI Innovations
    • June 7, 2022
      Strategies for Managing and Protecting Data (Intellectual Property Owners Association)
    • March 10, 2022
      Artificial Intelligence IP and Regulatory Legal Issues
    • March 9, 2022
      Artificial Intelligence IP and Regulatory Legal Issues
    • January 20, 2022
      Intellectual Property Primer
    • January 19, 2022
      AI in Drug Discovery and Development
    • November 11, 2021
      Artificial Intelligence in Drug Discovery and Development: IP Considerations
    • November 4, 2021
      Functional Claiming for Software Patents: Leveraging Recent Court Treatment
    • October 25, 2021
      IP Due Diligence in Life Sciences Acquisitions
    • September 21, 2021
      Data Issues and Best Practices Related to Artificial Intelligence Agreements (IPO Annual Meeting)
    • August 12, 2021
      Latest Developments in AI Intellectual Property and the U.S. Patent Trial and Appeal Board
    • August 10, 2021
      Protecting AI Innovations
    • July 29, 2021
      Due Diligence Considerations when Acquiring or Partnering with AI Companies
    • July 12, 2021
      Artificial Intelligence IP Considerations in the Biopharma Lifecycle
    • June 25, 2021
      Artificial Intelligence in Drug Discovery and Development: IP Considerations
    • June 23, 2021
      The Patent Trial and Appeal Board: An Influence on Every Patent Litigation Today
    • April 22, 2021
      AI Systems and Drafting Patents: Enablement and Inventorship - Overcoming Patent Eligibility, Inventorship, and Enablement Challenges and Avoiding Rejections
    • April 15, 2021
      Artificial Intelligence: Enforcement of AI IP and Use of AI in Discovery
    • April 13, 2021
      Brain Interfacing and the Patent System (AsiaIP)
    • January 28, 2021
      Preparing an IP Portfolio for an Exit
    • December 2020
      Strategies for Protecting AI and other Software-based Technologies in High Tech / Biotech
    • August 21, 2020
      Biopharma AI Patent Portfolio Development Strategies
    • July 2, 2020
      Claim Drafting for U.S. Patent Applications in Electrical, Software, and Mechanical Technologies
    • June 25, 2020
      Healthcare on the Other Side: Telehealth: Evolving to the Virtual Care of Tomorrow
    • June 8, 2020
      AI Innovations: To Patent or Not to Patent?
    • May 11, 2020
      The Allure of Trade Secrets: KnowIt
    • March 26, 2020
      Protection of Digital Health Innovations
    • February 2020
      Life & Medical Science AI Patent Protection Trends
    • January 23 2020
      Addressing Bias in Artificial Intelligence Systems
    • November 12, 2019
      AIPLA Artificial Intelligence and IP Workshop Road Show: Protection of Machine Learning Training Data
    • August 1, 2019
      Strategies for Protecting AI Innovations
    • June 2019
      IP Protection Trends in Artificial Intelligence, Bulgaria
    • June 2019
      IP Protection Trends in Artificial Intelligence, Germany
    • June 2019
      IP Protection Trends in Artificial Intelligence
    • June 2019
      Artificial Intelligence: Emerging Issues and Strategic IP Protection
    • September 20, 2018
      IP Protection for Artificial intelligence and Big Data Innovations in the Life Sciences, Boston Bar Association Life Sciences Conference
    • September 2018
      Patent Strategies for Medical Technologies Utilizing Artificial Intelligence
    • July 2018
      Artificial Intelligence Deployed in Medical Devices: Patent Strategies and Challenges
    • April 2018
      Patent Claim Drafting for Software / Artificial Intelligence Technologies (University of California, San Diego)
    • January 23, 2018
      Protecting Your AI-Related Innovations: Trade Secrets or Patents?
    • June 2017
      Big Data and Cloud Computing: Strategies for Patent and Trade Secret Protection
    • January 2017
      Strategic Patent Protection of Software and AI-Based Innovations
    • November 2016
      Litigation-Focused Patent Prosecution
    • October 2016
      Update On Patentability Of Computer Implemented Inventions
    • May 2016
      Update on U.S. Protection of Computer Implemented Inventions
    • January 20, 2016
      Recent Developments in IP Law and Their Implications
    • November 17, 2015
      IP ConfEx: Becoming a Better IP professional and Legal Advisor: Soft Skills for Navigating a Contentious, Globalized Environment